Snapshot from Sep 12, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech medical research

Bipolar disorder treatment review published

Analysis based on 10 articles · First reported Aug 11, 2026 · Last updated Aug 26, 2026

Sentiment
20
Attention
2
Articles
10
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The publication may influence clinical prescribing patterns for bipolar disorder, potentially benefiting pharmaceutical companies whose drugs are identified as effective. However, the direct market impact is limited as the review does not introduce new treatments but consolidates existing evidence.

Healthcare Pharmaceuticals

An international research team led by The Ottawa Hospital, in collaboration with the University of Barcelona, University of Padua, Paris Nanterre University, and University of Southampton, published a comprehensive living umbrella review in The BMJ identifying the most effective treatments for bipolar disorder across age groups and mood phases. The review analyzed 77 meta-analyses covering 116 treatments and resulted in the creation of the EBI-BD open-access web platform, which presents treatment efficacy, side effects, and evidence strength. The findings have been used to update guidelines from the International Society for Bipolar Disorders and the Canadian Network for Mood and Anxiety Treatments. The project was funded by the Canada — Canadian Institutes of Health Research, France — Agence nationale de la recherche, and the United Kingdom — National Institute for Health and Care Research.

90 The Ottawa Hospital published review
80 The Ottawa Hospital created platform
priv
Lead institution of the research team; created the EBI-BD platform and published the review in The BMJ.
Importance 100.0 Sentiment 20.0
oth
Collaborating institution; Corentin Gosling involved in the project.
Importance 60.0 Sentiment 5.0
per
Lead author and spokesperson; contributed to the review and platform development.
Importance 60.0 Sentiment 5.0
ngo
Updated its treatment guidelines based on the review findings.
Importance 50.0 Sentiment 5.0
ngo
Updated its treatment guidelines based on the review findings.
Importance 50.0 Sentiment 5.0
per
Co-author and senior researcher at The Ottawa Hospital; emphasized shared decision-making.
Importance 50.0 Sentiment 5.0
per
Co-author and lead researcher at The Ottawa Hospital; highlighted the platform's utility.
Importance 50.0 Sentiment 5.0
per
Co-author from University of Southampton; advocated for living reviews.
Importance 50.0 Sentiment 5.0
govactor
Provided funding for the research.
Importance 40.0 Sentiment 5.0
govactor
Provided funding for the research.
Importance 40.0 Sentiment 5.0
govactor
Provided funding for the research.
Importance 40.0 Sentiment 5.0
per
Co-author from Paris Nanterre University; involved in platform development.
Importance 40.0 Sentiment 5.0
per
Co-author from Robert Debré Hospital; commented on efficiency of living reviews.
Importance 30.0 Sentiment 5.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.